Skip to main content
. 2007 Oct 31;7:34. doi: 10.1186/1472-6882-7-34

Figure 6.

Figure 6

Sequential changes in total WOMAC scores (pain, stiffness and function) for reparagen (red, n = 48) and glucosamine (blue, n = 47). Both treatments resulted in a significant reduction in baseline WOMAC total scores from week 1 (reparagen p < 0.01, glucosamine p < 0.05), with further improvements with sustained administration (p < 0.001).